carbostyril has been researched along with Graves Ophthalmopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichinose, A; Kakizaki, H; Takahashi, Y | 1 |
| Dayan, CM; Ji, QH; Lane, C; Ludgate, M; Morris, D; Ruge, F; Tee, AR; Zhang, L | 1 |
2 other study(ies) available for carbostyril and Graves Ophthalmopathy
| Article | Year |
|---|---|
Topical rebamipide treatment for superior limbic keratoconjunctivitis in patients with thyroid eye disease.
Topics: Administration, Topical; Adult; Aged; Alanine; Antioxidants; Female; Fluorescein; Fluorescent Dyes; Graves Ophthalmopathy; Humans; Keratoconjunctivitis; Limbus Corneae; Male; Middle Aged; Ophthalmic Solutions; Osmolar Concentration; Quinolones; Retrospective Studies; Rose Bengal; Tears; Treatment Outcome | 2014 |
Reversal of Pathological Features of Graves' Orbitopathy by Activation of Forkhead Transcription Factors, FOXOs.
Topics: Adipogenesis; Adult; Female; Forkhead Transcription Factors; Glucuronosyltransferase; Graves Ophthalmopathy; Humans; Hyaluronan Synthases; Hyaluronic Acid; In Vitro Techniques; Middle Aged; Phosphatidylinositol 3-Kinase; Quinolones; Receptors, Thyrotropin; RNA, Small Interfering; Subcutaneous Fat; Transcriptional Activation; Trifluoperazine | 2016 |